[COPD Update 2015: Cell Biology goes Clinic? - Important Research Findings for Clinicians]
B Schmeck1, L Jerrentrup1, R Bals2
1Institut für Lungenforschung, Mitglied des Deutschen Zentrums für Lungenforschung (DZL), Philipps-Universität Marburg, Marburg.
Chronic obstructive pulmonary disease (COPD) presents limited treatment options due to incomplete understanding of its pathophysiology. This review explores current clinical and experimental research to improve COPD management and patient stratification.
Area of Science:
- Pulmonology
- Internal Medicine
- Pathophysiology
Background:
- Chronic obstructive pulmonary disease (COPD) is a prevalent, non-contagious disease with significant global mortality and socioeconomic impact.
- Current clinical assessment of COPD is comprehensive, including lung function, exacerbations, physical capacity, dyspnea, and comorbidities.
- Therapeutic options for COPD remain limited, with few drugs addressing the underlying pathophysiology.
Purpose of the Study:
- To review current progress in clinical and experimental COPD research.
- To highlight the need for improved understanding of COPD pathophysiology.
- To inform clinical practice by presenting advancements in COPD management.
Main Methods:
- Review of current clinical and experimental research on COPD.
- Analysis of existing therapeutic options and their limitations.
- Discussion of the role of pathophysiology in disease progression and treatment.
Main Results:
- Limited availability of causative therapeutic principles for COPD.
- Lack of clear biomarkers for patient stratification.
- Current anti-inflammatory treatments (inhaled glucocorticoids, PDE4 inhibitors) benefit only subgroups of patients.
Conclusions:
- A deeper understanding of COPD pathophysiology is crucial for developing effective treatments.
- Improved biomarkers are needed for precise patient stratification.
- This review synthesizes current research to guide future clinical practice and therapeutic development in COPD.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...


